Integrative Health Technologies, Inc. (IHTI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2009 | 297.94 Thousand USD | 0.0% |
| 2006 | 434.94 Thousand USD | -54.62% |
| 2005 | 958.53 Thousand USD | -24.09% |
| 2004 | 1.26 Million USD | 107.04% |
| 2003 | 609.9 Thousand USD | 1815.18% |
| 2002 | 31.84 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2009 FY | 297.94 Thousand USD | 0.0% |
| 2007 Q1 | 620.75 Thousand USD | 42.72% |
| 2007 Q2 | 225.17 Thousand USD | -63.73% |
| 2007 Q3 | 225.17 Thousand USD | 0.0% |
| 2006 Q4 | 434.94 Thousand USD | 14.09% |
| 2006 Q2 | 1 Million USD | -1.32% |
| 2006 Q1 | 1.02 Million USD | 6.44% |
| 2006 FY | 434.94 Thousand USD | -54.62% |
| 2006 Q3 | 381.22 Thousand USD | -62.13% |
| 2005 FY | 958.53 Thousand USD | -24.09% |
| 2005 Q4 | 958.53 Thousand USD | 39.48% |
| 2005 Q2 | 694.07 Thousand USD | -8.41% |
| 2005 Q1 | 757.83 Thousand USD | -39.98% |
| 2005 Q3 | 687.2 Thousand USD | -0.99% |
| 2004 Q2 | 753.13 Thousand USD | -3.77% |
| 2004 Q3 | 854.85 Thousand USD | 13.51% |
| 2004 FY | 1.26 Million USD | 107.04% |
| 2004 Q4 | 1.26 Million USD | 47.71% |
| 2004 Q1 | 782.64 Thousand USD | 28.32% |
| 2003 Q1 | 34.74 Thousand USD | 9.1% |
| 2003 FY | 609.9 Thousand USD | 1815.18% |
| 2003 Q4 | 609.9 Thousand USD | 62.35% |
| 2003 Q3 | 375.67 Thousand USD | 2421.83% |
| 2003 Q2 | 14.89 Thousand USD | -57.12% |
| 2002 Q4 | 31.84 Thousand USD | -2.45% |
| 2002 FY | 31.84 Thousand USD | 0.0% |
| 2002 Q3 | 32.64 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| American Bio Medica Corporation | 3.6 Million USD | 91.742% |
| Arrayit Corporation | 7.49 Million USD | 96.026% |
| Atlantic International Corp. | 3.82 Million USD | 92.218% |
| Biocept, Inc. | 22.01 Million USD | 98.646% |
| Bioqual, Inc. | 18.93 Million USD | 98.427% |
| CardioGenics Holdings Inc | 1.79 Million USD | 83.401% |
| DermTech, Inc. | 64.75 Million USD | 99.54% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 734.97 Million USD | 99.959% |
| HTG Molecular Diagnostics, Inc. | 12.38 Million USD | 97.594% |
| iMD Companies, Inc. | 1.67 Million USD | 82.204% |
| IDenta Corp. | 1.01 Million USD | 70.592% |
| Interpace Biosciences, Inc. | 28.15 Million USD | 98.942% |
| InVitro International | 78.99 Thousand USD | -277.196% |
| Lumos Diagnostics Holdings Limited | 19.72 Million USD | 98.49% |
| Many Bright Ideas Technologies Inc. | 129.29 Thousand USD | -130.436% |
| Medical Imaging Corp. | 9.51 Million USD | 96.869% |
| NovelStem International Corp. | 4.2 Million USD | 92.916% |
| Optigenex Inc. | 9.57 Million USD | 96.887% |
| PharmChem, Inc. | 558.64 Thousand USD | 46.666% |
| Proteome Sciences plc | 18.48 Million USD | 98.389% |
| Response Genetics, Inc | 15.86 Million USD | 98.122% |
| Rennova Health, Inc. | 49.66 Million USD | 99.4% |
| RushNet, Inc. | 6.23 Million USD | 95.224% |
| ScreenPro Security Inc. | 1.6 Million USD | 81.385% |
| Stella Diagnostics Inc. | 18 Million USD | 98.345% |
| StageZero Life Sciences Ltd. | 8.2 Million USD | 96.368% |
| Todos Medical Ltd. | 50.15 Million USD | 99.406% |